Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01393483 · ClinicalTrials.gov registry record
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 371
- Enrollment target
NCT01393483: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01393483 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 371 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01393483 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 371 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether a protein, called mesothelin, found in the blood and tissue can be used as "marker" for esophageal cancer. Doctors at Memorial Sloan-Kettering Cancer Center would like to compare levels of this protein in patients with abnormal cells or tissue of the esophageal to the levels of this protein in patients being treated for cancer for the esophagus.
Primary Outcome
The investigators will examine the range and variability in the percentage on cells stained (for TM) and in the absolute value (for SM). TM expression is commonly analyzed in a binary fashion, with 25% of cells stained indicating positive expression (per standard pathological guidelines for tissue staining)
Interventions
- OTHER serum and tissue mesothelin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2011-03 |
| Est. Completion | 2024-10-22 |
What the finished NCT01393483 record still lists
NCT01393483 is an observational study that tracks outcomes without assigning an intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which serum and tissue mesothelin is the first listed.
NCT01393483 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01393483 about?
NCT01393483 is a clinical study titled "Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)". The purpose of this study is to find out whether a protein, called mesothelin, found in the blood and tissue can be used as "marker" for esophageal cancer. Doctors at Memorial Sloan-Kettering Cancer Center would like to compare levels of this protein in patients with abnormal cells or tissue of the ...
What is the current status of trial NCT01393483?
This trial is currently completed. The enrollment target is 371 participants. The study started on 2011-03. Estimated completion is 2024-10-22.
What interventions are being tested in trial NCT01393483?
The interventions under investigation include: serum and tissue mesothelin (OTHER).
Who is sponsoring clinical trial NCT01393483?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05743673 · 371 participants
SHAPE Test for Preoperative Risk Stratification
- NCT05761847 · 371 participants · NA
Pediatric Medication Therapy Management Trial
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia